The World Trade Organization is currently discussing a waiver for COVID-19 vaccine patent protections. If approved, countries could recreate vaccines without worrying about sanctions.
Mr. Bancel said waiving COVID-19 patent protections “doesn’t change anything for Moderna,” as its vaccine uses mRNA technology.
“There is no mRNA in manufacturing capacity in the world,” Mr. Bancel said. “This is a new technology. You cannot go hire people who know how to make the mRNA. Those people don’t exist.”
Moderna has not been particularly protective when it comes to sharing its COVID-19 vaccine intellectual property. In October, the drugmaker said it would not enforce the vaccine’s patent rights while the pandemic continues, adding it is also willing to license the vaccine’s intellectual property to others after the pandemic.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
